Platforms
Numerous platforms in the field of bioimaging, molecular biology, vectorology, histology and experimental models support the technological programmes.
Bio-imaging center (BIC)
The Bordeaux Imaging Center (BIC) provides services, training and technological innovation in cellular imaging to academic and private scientific communities, mainly in life, health and plant sciences. It is a core facility identified at the national level as “Infrastructure en Biologie Sante et Agronomie“ (IBISA). The BIC is part of the France BioImaging network, and Euro BioImaging network. |
CGFB - Functional Genomic Center of Bordeaux
| The Centre for Functional Genomics Bordeaux is a federation of technology platforms, all labeled IBiSA, offering all the scientific communities access to equipment, techniques and expertise for the study of Life Sciences. The Centre provides to Bordeaux and the Aquitaine Region a center of excellence in the field of Life Sciences. |
Clinical Research Center of Bordeaux
The Clinical Research Centre (CIC 1401) of Bordeaux University Hospital Center is a particular organization which principal objective is to favour translational research in health. It is an interface between researchers, clinicians and companies that facilitates the “bench to bed side” transfer of innovation and knowledge. It depends on BUMC, Inserm, Bergonié Institute and University of Bordeaux. Its main mission is to give the resources and appropriate support for realization of high quality research to local, national or international researchers whatever the type of sponsor. It provides its services to investigators and researchers in the fields of excellence of the strategy plan of BUMC: neurosciences, cancer, cardio-thoracic pathologies, infectious diseases, public health, biomaterials and emerging ones such as imaging, liver-stomach-intestine pathologies, nephrology-nutrition and rare diseases. The CIC (directed par Pr Nicholas MOORE) is composed of 3 different teams:
|
Clinical Research Centre for Innovative Technologies (CRC-TI)
| The Clinical Research Centre for Innovative Technologies (CRC-TI) of Bordeaux University Hospital Center/Inserm is dedicated to Biomaterials and Implantable Medical Devices since 2001. The CRC‐TI is an interface for medical research valorization, aiming to make the proof of concept of technological innovation: its abilities take place between fundamental and clinical research in Biomaterials, Medical Devices and Tissue Engineering fields. Its expertise consists in studying, according to an integrated work plan, the biocompatibility and biofunctionality of biomaterials (in vitro direct cytotoxicity, cytocompatibility, in vivo biocompatibility and biofunctionality). Studies are performed following ISO 10993 standards. The CRC-TI is located in a scientific and clinical relevant environment (Bordeaux University Hospital, in the Technological Platform for Biomedical Innovation at Pessac). The CRC-TI proposes also to design and set up pilot clinical trials for first patients’ implantations of innovative biomaterial and tissue engineered products. Up to date, the CRC-TI has been involved in around 20 collaborative projects financed by the french National Agency for Research (ANR), different foundations (Agence de Biomédecine, Fondation de l’Avenir) and local and national Hospital Programmes for Clinical Research (PHRC and AOI). These projects have been conducted with academic and/or industrial partners. The CRC-TI is involved in the TECH4HEALTH platform. It is member of the 2ACBI association gathering all regional academic and industrial skills in biomaterials and medical devices. At the European level, the CRC-TI is involved in the ITECH project conducted by the French CRC-TI network. |
Placamat
| Placamat Aquitaine paltform (UMR 3624) offers to CNRS and Inserm laboratories innovative methods for the characterizations of materials and bioimaging. This platform is organized into three divisions whose equipments and skills are complementary: |
TBM Core
 | TBM Core is an association of technology platforms labeled by INSERM (US5), CNRS (UMS 3427) and Univesity of Bordeaux offering to Bordeaux research community an access to Flow Cytometry, Vectorology, Histology, quantitative PCR and Level 3 laboratory. The objective of TBMCore is to provide to scientists involved in basic and translational biological research state of the art equipment, expertise and training by specialized engineers. Involvement of several INSERM or CNRS laboratories of FR TransBioMed in TBMCore running warrants innovation and continuous upgrading of equipment and procedures. |
Technology Platform for Biomedical Innovation (PTIB)
The PTIB ensures technology transfer between experimental skills and clinical aspects, in strong interaction with industry. PTIB offers numerous technological platforms in the field of histology, molecular biology, preclinical assays in large animals. PTIB aims to develop and validate diagnostic or therapeutic tools, mainly for cardiovascular diseases, lung diseases and bone regeneration. |
Vivoptic
 | The in-vivo optical imaging component of UMS 3428 that includes 6-optical imaging devices for bioluminescence and fluorescence |
